SIGNALAI·Jun 24, 2026, 4:00 AMSignal75Medium term

RetiSEM: Generalising Causal Models for Fragmented Biomedical Data

Source: arXiv cs.AI

Share
RetiSEM: Generalising Causal Models for Fragmented Biomedical Data

arXiv:2606.24488v1 Announce Type: cross Abstract: Learning causal models from fragmented biomedical data is challenging because clinical, molecular, and imaging variables are often incomplete or not jointly observed. We propose RetiSEM, a domain-constrained structural equation modelling (SEM) framework for causal graph recovery and mediation analysis under limited multimodal resources. This proposed work organises variables into biologically informed blocks, applies forbidden-edge constraints, and decomposes pathway-level effects into TE, NDE, and NIE components. We evaluate RetiSEM across ten

Why this matters
Why now

The proliferation of fragmented, multimodal biomedical datasets necessitates new computational approaches to extract causal insights as AI continues to mature.

Why it’s important

This work represents progress in applying sophisticated AI techniques to complex biomedical data, potentially accelerating drug discovery, personalized medicine, and our understanding of disease.

What changes

The ability to accurately model causality and perform mediation analysis from incomplete biomedical data becomes more feasible, enhancing the utility of existing and future datasets.

Winners
  • · Biomedical researchers
  • · Pharmaceutical companies
  • · AI/ML developers in healthcare
  • · Personalized medicine initiatives
Losers
  • · Traditional statistical modeling approaches in fragmented data scenarios
  • · Diseases with complex, multi-factorial causes
Second-order effects
Direct

Improved understanding of disease pathways and more targeted therapeutic interventions.

Second

Reduced timelines and costs for drug development, leading to a faster transition of research into clinical practice.

Third

The integration of such models directly into clinical decision-making systems, enabling more proactive and precise patient care.

Editorial confidence: 90 / 100 · Structural impact: 60 / 100
Original report

This signal links to a primary source. Continuum Brief monitors and indexes it as part of the live intelligence stream — we do not republish source content.

Read at arXiv cs.AI
Tracked by The Continuum Brief · live intelligence network
Share
The Brief · Weekly Dispatch

Stay ahead of the systems reshaping markets.

By subscribing, you agree to receive updates from THE CONTINUUM BRIEF. You can unsubscribe at any time.